Cargando…
Aberrant DNA Methylation Status and mRNA Expression Level of SMG1 Gene in Chronic Myeloid Leukemia: A Case-Control Study
OBJECTIVE: Chronic myeloid leukemia (CML) is a myeloproliferative malignancy with different stages. Aberrant epigenetic modifications, such as DNA methylation, have been introduced as a signature for diverse cancers which also plays a crucial role in CML pathogenesis and development. Suppressor with...
Autores principales: | Hojjatipour, Tahereh, Sohani, Mahsa, Maali, Amirhosein, Rostami, Shahrbano, Azad, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790066/ https://www.ncbi.nlm.nih.gov/pubmed/36527348 http://dx.doi.org/10.22074/cellj.2022.8526 |
Ejemplares similares
-
Promoter Methylation Status and Expression Levels of RASSF1A Gene in Different Phases of Acute Lymphoblastic Leukemia (ALL)
por: Sohani, Mahsa, et al.
Publicado: (2021) -
Methylation and Expression Status of The CpG-Island of SMG1
Promoter in Acute Myeloid Leukemia: A Follow-Up
Study in Patients
por: Karami, Neda, et al.
Publicado: (2022) -
Aberrant Methylation of APAF-1 Gene in Acute Myeloid Leukemia Patients
por: Rostami, Shahrbano, et al.
Publicado: (2017) -
SMG5-SMG7 authorize nonsense-mediated mRNA decay by enabling SMG6 endonucleolytic activity
por: Boehm, Volker, et al.
Publicado: (2021) -
SMG5–PNRC2 is functionally dominant compared with SMG5–SMG7 in mammalian nonsense-mediated mRNA decay
por: Cho, Hana, et al.
Publicado: (2013)